AML (ACUTE MYELOGENOUS LEUKEMIA)
Clinical trials for AML (ACUTE MYELOGENOUS LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new AML (ACUTE MYELOGENOUS LEUKEMIA) trials appear
Sign up with your email to follow new studies for AML (ACUTE MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers? early trial of CG009301 begins
Disease control Recruiting nowThis early-phase study tests a new drug called CG009301 in adults with blood cancers (like leukemia or MDS) that returned or didn't respond to standard treatments. The main goals are to find a safe dose and see if the drug can help control the disease. About 45 participants will …
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
New drug cocktails aim to tame deadly transplant complication
Disease control Recruiting nowThis study is for people with blood cancers who need a stem cell transplant from an unrelated donor with a different blood type. The goal is to find which drug combination works best to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the …
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New hope for kids with down syndrome and leukemia: gentler chemo shows promise
Disease control Recruiting nowThis study tests a chemotherapy plan designed specifically for children (0-18 years) with acute myeloid leukemia (AML) and Down syndrome. The goal is to improve survival while reducing harsh side effects by using lower doses of chemotherapy drugs. About 100 children in Russia wil…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE3 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Broccoli compound may boost recovery after cord blood transplant
Disease control Recruiting nowThis study tests whether a dietary supplement called sulforaphane (found in broccoli) can safely help blood cell recovery in adults receiving a cord blood transplant for blood cancers like leukemia or MDS. The cord blood used has been frozen for 10 years or more, which can damage…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New combo aims to match AML patients with the right treatment
Disease control Recruiting nowThis study tests whether adding the targeted drug venetoclax to standard intensive chemotherapy improves outcomes for adults with acute myeloid leukemia (AML). The goal is to find out which genetic subtypes of AML respond best to this combination. About 380 participants aged 14 t…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Blood test may predict chemo side effects in leukemia patients
Knowledge-focused Recruiting nowThis study is for adults with acute myeloid leukemia (AML) who are in remission after treatment with a combination of venetoclax and a hypomethylating agent. The goal is to see if the amount of venetoclax in the blood is linked to severe low white blood cell counts (neutropenia).…
Matched conditions: AML (ACUTE MYELOGENOUS LEUKEMIA)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC